On September 24, 2025, Ye Ping, Party Branch Secretary of Changlei Law Firm, was invited to conduct a "Specialized Training on Corporate Compliance" for Shanghai Tongjitang Pharmaceutical Co., Ltd. (hereinafter referred to as "Tongjitang Pharmaceutical"). Nearly thirty senior and middle-level managers from Tongjitang Pharmaceutical attended the session.
As regulatory policies in the pharmaceutical industry become increasingly stringent and the market environment grows more complex and volatile, enterprises face numerous opportunities and challenges in achieving high-quality development and managing compliance. To assist Tongjitang Pharmaceutical in further enhancing its compliance management standards and strengthening its legal risk prevention capabilities, Lawyer Ye Ping "tailored" the course content and presentation materials for this lecture based on a questionnaire survey conducted within the company.
Centered on the theme of "Corporate Compliance," the lecture was divided into eight major sections: Human Resources, Procurement, Sales, Construction Engineering, Finance and Taxation, Information Technology, Contract Management, and Litigation Response. Drawing upon her professional medical background and practical experience serving pharmaceutical enterprises, Lawyer Ye Ping used a wealth of vivid and detailed cases to provide an accessible yet profound analysis of key compliance management points and risk control measures within these eight sectors. She also engaged in interactive exchanges with the attendees to answer questions and clarify doubts, receiving high praise from the participants.
Since Tongjitang Pharmaceutical and Changlei Law Firm signed the standing legal counsel service agreement in June 2024, Changlei Law Firm has consistently adhered to the core values of "Responsibility, Integrity, and Quality,"
Shanghai Tongjitang Pharmaceutical Co., Ltd. (hereinafter referred to as "Tongjitang Pharmaceutical") was established in August 2002. In October 2016, it was officially acquired by China National Traditional Chinese Medicine (TCM) Co., Ltd., a subsidiary of China National Pharmaceutical Group Co., Ltd. (Sinopharm), becoming a TCM decoction pieces enterprise under the Sinopharm Group and officially entering the ranks of central state-owned enterprises.
Located in Qingpu District, Shanghai, Tongjitang Pharmaceutical covers an area of over 60 mu with a registered capital of 80 million RMB. The company currently employs over 600 staff members and operates as a modern TCM enterprise integrating research and development, production, and sales. It holds the distinction of being the first enterprise in the nation to provide hospital-based decoction services. Collaborating with approximately 90 medical institutions in Shanghai, the company processes over 36 million doses of medicine annually and simultaneously offers customized personalized cream formula (Gao Fang) services.